Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathy or islet cell dysfunction?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effects of thyrotropin-releasing hormone on regional cerebral blood flow in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Plasma glucagon and glucose recovery after hypoglycemia: the effect of total autonomic blockade

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Intensive screening for osteoporosis in patients with hip fracture

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fracture risk in women with type II diabetes. Results from a historical cohort with fracture follow-up

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
A non-invasive evaluation of bone metabolism was performed in 44 morbidly obese patients before and after a mean weight loss of 22.4 kg (range 7.9-43.4 kg) after 2 months and a further weight loss of 7.3 kg after 8 months (0.8-20.0 kg). This weight reduction was obtained by a nutritionally adequate very-low-calorie diet. Before treatment the bone mineral content of the distal forearm was increased compared to normals (51.9 U vs. 43.7 U, p < 0.001). Bone formation was evaluated by serum alkaline phosphatase and serum osteocalcin. Serum alkaline phosphatase was increased (187.8 U/l vs 147.4 U/l, p < 0.001) while serum osteocalcin was lower than in the controls (0.67 nmol/l vs 0.98 nmol/l, p < 0.01). Bone resorption, as measured by the urinary hydroxyproline/creatinine ratio, was not increased in the obese patients (19.2 molar ratio x 10(-3) vs 16.7 molar ratio x 10(-3), NS). After 2 months, the bone mineral content had declined by 3.3%. Serum alkaline phosphatase remained unchanged (187.8 U/l vs 186.9 U/l, NS) but serum osteocalcin demonstrated a significant rise (3.94 nmol/l vs 10.53 nmol/l, p < 0.001), parallel to changes in the hydroxyproline/creatinine ratio (19.2 molar ratio x 10(-3) vs 25.2 molar ratio x 10(-3), p < 0.001). At 8 months, no further change in the bone mineral content was seen. The hydroxyproline/creatinine ratio did still increase (from 25.8 molar ratio x 10(-3) to 30.1 molar ratio x 10(-3), p < 0.05), while serum alkaline phosphatase and serum osteocalcin remained unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
Translated title of the contributionBone metabolism in obesity: changes related to severe overweight and dietary weight reduction.
Original languageEnglish
JournalActa Endocrinologica (Copenh)
Volume129
Issue number5
Pages (from-to)393-398
Number of pages6
ISSN0001-5598
Publication statusPublished - 1993

ID: 32571432